发明公开
EP1121125A1 PHARMACEUTICAL FORMULATIONS FOR USE IN ESTROGEN DEPRIVATION SYNDROME
审中-公开
用于雌激素剥夺综合症的药物制剂
- 专利标题： PHARMACEUTICAL FORMULATIONS FOR USE IN ESTROGEN DEPRIVATION SYNDROME
- 专利标题（中）： 用于雌激素剥夺综合症的药物制剂
-
申请号： EP99954711.0申请日： 1999-10-01
-
公开(公告)号： EP1121125A1公开(公告)日： 2001-08-08
- 发明人: CULLINAN, George, Joseph , MUEHL, Brian, Stephen , THRASHER, Kenneth, Jeff
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 代理机构： Vaughan, Jennifer Ann
- 优先权： US104011P 19981013
- 国际公布： WO0021535 20000420
- 主分类号： A61K31/445
- IPC分类号： A61K31/445 ; A61K31/40 ; A61P3/06 ; A61P5/30 ; A61P19/10 ; A61P25/28
摘要：
Formulations and applications thereof are described which are useful for the inhibition of various medical conditions associated with estrogen deprivation syndrome including osteoporosis and hyperlipidemia utilizing compounds of structure (I) in combination with compounds of formula (II) where X, Y, R, R', R?6, R7, and R8¿ are as defined herein.
信息查询
IPC分类:
